Correlation Between DiaMedica Therapeutics and RenovoRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and RenovoRx, you can compare the effects of market volatilities on DiaMedica Therapeutics and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and RenovoRx.

Diversification Opportunities for DiaMedica Therapeutics and RenovoRx

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between DiaMedica and RenovoRx is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and RenovoRx go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and RenovoRx

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.58 times less return on investment than RenovoRx. But when comparing it to its historical volatility, DiaMedica Therapeutics is 1.79 times less risky than RenovoRx. It trades about 0.08 of its potential returns per unit of risk. RenovoRx is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  62.00  in RenovoRx on September 3, 2024 and sell it today you would earn a total of  65.00  from holding RenovoRx or generate 104.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  RenovoRx

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
RenovoRx 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

DiaMedica Therapeutics and RenovoRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and RenovoRx

The main advantage of trading using opposite DiaMedica Therapeutics and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.
The idea behind DiaMedica Therapeutics and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format